Value of machine learning-based transrectal multimodal ultrasound combined with PSA-related indicators in the diagnosis of clinically significant prostate cancer

ObjectiveTo investigate the effect of transrectal multimodal ultrasound combined with serum prostate-specific antigen (PSA)-related indicators and machine learning for the diagnosis of clinically significant prostate cancer.MethodsBased on Gleason score of postoperative pathological results, the sub...

Full description

Bibliographic Details
Main Authors: Maoliang Zhang, Yuanzhen Liu, Jincao Yao, Kai Wang, Jing Tu, Zhengbiao Hu, Yun Jin, Yue Du, Xingbo Sun, Liyu Chen, Zhengping Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1137322/full
_version_ 1811158308851023872
author Maoliang Zhang
Yuanzhen Liu
Yuanzhen Liu
Yuanzhen Liu
Jincao Yao
Jincao Yao
Jincao Yao
Kai Wang
Jing Tu
Zhengbiao Hu
Yun Jin
Yue Du
Xingbo Sun
Liyu Chen
Liyu Chen
Zhengping Wang
author_facet Maoliang Zhang
Yuanzhen Liu
Yuanzhen Liu
Yuanzhen Liu
Jincao Yao
Jincao Yao
Jincao Yao
Kai Wang
Jing Tu
Zhengbiao Hu
Yun Jin
Yue Du
Xingbo Sun
Liyu Chen
Liyu Chen
Zhengping Wang
author_sort Maoliang Zhang
collection DOAJ
description ObjectiveTo investigate the effect of transrectal multimodal ultrasound combined with serum prostate-specific antigen (PSA)-related indicators and machine learning for the diagnosis of clinically significant prostate cancer.MethodsBased on Gleason score of postoperative pathological results, the subjects were divided into clinically significant prostate cancer groups(GS>6)and non-clinically significant prostate cancer groups(GS ≤ 6). The independent risk factors were obtained by univariate logistic analysis. Artificial neural network (ANN), logistic regression (LR), support vector machine (SVM), decision tree (DT), random forest (RF), and K-nearest neighbor (KNN) machine learning models were combined with clinically significant prostate cancer risk factors to establish the machine learning model, calculate the model evaluation indicators, construct the receiver operating characteristic curve (ROC), and calculate the area under the curve (AUC).ResultsIndependent risk factor items (P< 0.05) were entered into the machine learning model. A comparison of the evaluation indicators of the model and the area under the ROC curve showed the ANN model to be best at predicting clinically significant prostate cancer, with a sensitivity of 80%, specificity of 88.6%, F1 score of 0.897, and the AUC was 0.855.ConclusionEstablishing a machine learning model by rectal multimodal ultrasound and combining it with PSA-related indicators has definite application value in predicting clinically significant prostate cancer.
first_indexed 2024-04-10T05:22:18Z
format Article
id doaj.art-4c6986066af24494bed073c05a0a6cec
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-04-10T05:22:18Z
publishDate 2023-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-4c6986066af24494bed073c05a0a6cec2023-03-08T06:48:46ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922023-03-011410.3389/fendo.2023.11373221137322Value of machine learning-based transrectal multimodal ultrasound combined with PSA-related indicators in the diagnosis of clinically significant prostate cancerMaoliang Zhang0Yuanzhen Liu1Yuanzhen Liu2Yuanzhen Liu3Jincao Yao4Jincao Yao5Jincao Yao6Kai Wang7Jing Tu8Zhengbiao Hu9Yun Jin10Yue Du11Xingbo Sun12Liyu Chen13Liyu Chen14Zhengping Wang15Department of Ultrasound, The Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, ChinaDepartment of Ultrasound, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, ChinaInstitute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, ChinaKey Laboratory of Head & Neck Cancer Translational Research of Zhejiang Province, Hangzhou, Zhejiang, ChinaDepartment of Ultrasound, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, ChinaInstitute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, ChinaKey Laboratory of Head & Neck Cancer Translational Research of Zhejiang Province, Hangzhou, Zhejiang, ChinaDepartment of Ultrasound, The Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, ChinaDepartment of Ultrasound, The Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, ChinaDepartment of Ultrasound, The Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, ChinaDepartment of Ultrasound, The Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, ChinaDepartment of Ultrasound, The Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, ChinaDepartment of Ultrasound, The Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, ChinaDepartment of Ultrasound, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, ChinaInstitute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, ChinaDepartment of Ultrasound, The Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, ChinaObjectiveTo investigate the effect of transrectal multimodal ultrasound combined with serum prostate-specific antigen (PSA)-related indicators and machine learning for the diagnosis of clinically significant prostate cancer.MethodsBased on Gleason score of postoperative pathological results, the subjects were divided into clinically significant prostate cancer groups(GS>6)and non-clinically significant prostate cancer groups(GS ≤ 6). The independent risk factors were obtained by univariate logistic analysis. Artificial neural network (ANN), logistic regression (LR), support vector machine (SVM), decision tree (DT), random forest (RF), and K-nearest neighbor (KNN) machine learning models were combined with clinically significant prostate cancer risk factors to establish the machine learning model, calculate the model evaluation indicators, construct the receiver operating characteristic curve (ROC), and calculate the area under the curve (AUC).ResultsIndependent risk factor items (P< 0.05) were entered into the machine learning model. A comparison of the evaluation indicators of the model and the area under the ROC curve showed the ANN model to be best at predicting clinically significant prostate cancer, with a sensitivity of 80%, specificity of 88.6%, F1 score of 0.897, and the AUC was 0.855.ConclusionEstablishing a machine learning model by rectal multimodal ultrasound and combining it with PSA-related indicators has definite application value in predicting clinically significant prostate cancer.https://www.frontiersin.org/articles/10.3389/fendo.2023.1137322/fullclinically significant prostate cancermultimodal ultrasoundserum prostate specific antigenmachine learningartificial neural network
spellingShingle Maoliang Zhang
Yuanzhen Liu
Yuanzhen Liu
Yuanzhen Liu
Jincao Yao
Jincao Yao
Jincao Yao
Kai Wang
Jing Tu
Zhengbiao Hu
Yun Jin
Yue Du
Xingbo Sun
Liyu Chen
Liyu Chen
Zhengping Wang
Value of machine learning-based transrectal multimodal ultrasound combined with PSA-related indicators in the diagnosis of clinically significant prostate cancer
Frontiers in Endocrinology
clinically significant prostate cancer
multimodal ultrasound
serum prostate specific antigen
machine learning
artificial neural network
title Value of machine learning-based transrectal multimodal ultrasound combined with PSA-related indicators in the diagnosis of clinically significant prostate cancer
title_full Value of machine learning-based transrectal multimodal ultrasound combined with PSA-related indicators in the diagnosis of clinically significant prostate cancer
title_fullStr Value of machine learning-based transrectal multimodal ultrasound combined with PSA-related indicators in the diagnosis of clinically significant prostate cancer
title_full_unstemmed Value of machine learning-based transrectal multimodal ultrasound combined with PSA-related indicators in the diagnosis of clinically significant prostate cancer
title_short Value of machine learning-based transrectal multimodal ultrasound combined with PSA-related indicators in the diagnosis of clinically significant prostate cancer
title_sort value of machine learning based transrectal multimodal ultrasound combined with psa related indicators in the diagnosis of clinically significant prostate cancer
topic clinically significant prostate cancer
multimodal ultrasound
serum prostate specific antigen
machine learning
artificial neural network
url https://www.frontiersin.org/articles/10.3389/fendo.2023.1137322/full
work_keys_str_mv AT maoliangzhang valueofmachinelearningbasedtransrectalmultimodalultrasoundcombinedwithpsarelatedindicatorsinthediagnosisofclinicallysignificantprostatecancer
AT yuanzhenliu valueofmachinelearningbasedtransrectalmultimodalultrasoundcombinedwithpsarelatedindicatorsinthediagnosisofclinicallysignificantprostatecancer
AT yuanzhenliu valueofmachinelearningbasedtransrectalmultimodalultrasoundcombinedwithpsarelatedindicatorsinthediagnosisofclinicallysignificantprostatecancer
AT yuanzhenliu valueofmachinelearningbasedtransrectalmultimodalultrasoundcombinedwithpsarelatedindicatorsinthediagnosisofclinicallysignificantprostatecancer
AT jincaoyao valueofmachinelearningbasedtransrectalmultimodalultrasoundcombinedwithpsarelatedindicatorsinthediagnosisofclinicallysignificantprostatecancer
AT jincaoyao valueofmachinelearningbasedtransrectalmultimodalultrasoundcombinedwithpsarelatedindicatorsinthediagnosisofclinicallysignificantprostatecancer
AT jincaoyao valueofmachinelearningbasedtransrectalmultimodalultrasoundcombinedwithpsarelatedindicatorsinthediagnosisofclinicallysignificantprostatecancer
AT kaiwang valueofmachinelearningbasedtransrectalmultimodalultrasoundcombinedwithpsarelatedindicatorsinthediagnosisofclinicallysignificantprostatecancer
AT jingtu valueofmachinelearningbasedtransrectalmultimodalultrasoundcombinedwithpsarelatedindicatorsinthediagnosisofclinicallysignificantprostatecancer
AT zhengbiaohu valueofmachinelearningbasedtransrectalmultimodalultrasoundcombinedwithpsarelatedindicatorsinthediagnosisofclinicallysignificantprostatecancer
AT yunjin valueofmachinelearningbasedtransrectalmultimodalultrasoundcombinedwithpsarelatedindicatorsinthediagnosisofclinicallysignificantprostatecancer
AT yuedu valueofmachinelearningbasedtransrectalmultimodalultrasoundcombinedwithpsarelatedindicatorsinthediagnosisofclinicallysignificantprostatecancer
AT xingbosun valueofmachinelearningbasedtransrectalmultimodalultrasoundcombinedwithpsarelatedindicatorsinthediagnosisofclinicallysignificantprostatecancer
AT liyuchen valueofmachinelearningbasedtransrectalmultimodalultrasoundcombinedwithpsarelatedindicatorsinthediagnosisofclinicallysignificantprostatecancer
AT liyuchen valueofmachinelearningbasedtransrectalmultimodalultrasoundcombinedwithpsarelatedindicatorsinthediagnosisofclinicallysignificantprostatecancer
AT zhengpingwang valueofmachinelearningbasedtransrectalmultimodalultrasoundcombinedwithpsarelatedindicatorsinthediagnosisofclinicallysignificantprostatecancer